Early life poly- and perfluoroalkyl substance levels and adiposity in the first 2 years of life.

IF 5.3 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Inge A L P van Beijsterveldt, Bertrand D van Zelst, Demi J Dorrepaal, Sjoerd A A van den Berg, Anita C S Hokken-Koelega
{"title":"Early life poly- and perfluoroalkyl substance levels and adiposity in the first 2 years of life.","authors":"Inge A L P van Beijsterveldt, Bertrand D van Zelst, Demi J Dorrepaal, Sjoerd A A van den Berg, Anita C S Hokken-Koelega","doi":"10.1093/ejendo/lvae039","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Poly- and perfluoroalkyl substances (PFASs) are nondegradable, man-made chemicals. They accumulate in humans with potential harmful effects, especially in susceptible periods of human development, such as the first months of life. We found that, in our cohort, exclusively breastfed (EBF) infants had 3 times higher PFAS plasma levels compared with exclusively formula-fed (EFF) infants at the age of 3 months. Thus, PFASs could potentially reduce the health benefits of breastfeeding.</p><p><strong>Objective: </strong>We investigated the associations between PFAS levels at the age of 3 months and accelerated gain in fat mass during the first 6 months of life, body composition at 2 years, and whether these associations differ between EBF and EFF infants.</p><p><strong>Setting: </strong>In 372 healthy term-born infants, we longitudinally assessed anthropometrics, body composition (by air-displacement plethysmography and dual-energy X-ray absorptiometry), and visceral and subcutaneous fat (by abdominal ultrasound) until the age of 2 years.</p><p><strong>Measures: </strong>The plasma levels of 5 individual PFASs were determined by liquid chromatography-electrospray ionization-tandem mass spectrometry at the age of 3 months.</p><p><strong>Main outcomes: </strong>We studied associations between PFAS levels and outcomes using multiple regression analyses.</p><p><strong>Results: </strong>Higher early life plasma perfluorooctanoic acid and total PFAS levels were associated with an accelerated gain in fat mass percentage [FM%; >0.67 SD score (SDS)] during the first 6 months of life. Higher early life PFAS levels were associated with lower fat-free mass (FFM) SDS at the age of 2 years, but not with total FM% SDS at 2 years. Furthermore, we found opposite effects of PFAS levels (negative) and exclusive breastfeeding (positive) at the age of 3 months on FFM SDS at 2 years.</p><p><strong>Conclusion: </strong>Higher PFAS levels in early life are associated with accelerated gains in FM% during the first 6 months of life and with lower FFM SDS at the age of 2 years, which have been associated with an unfavorable body composition and metabolic profile later in life. Our findings warrant further research with longer follow-up times.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":null,"pages":null},"PeriodicalIF":5.3000,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvae039","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Poly- and perfluoroalkyl substances (PFASs) are nondegradable, man-made chemicals. They accumulate in humans with potential harmful effects, especially in susceptible periods of human development, such as the first months of life. We found that, in our cohort, exclusively breastfed (EBF) infants had 3 times higher PFAS plasma levels compared with exclusively formula-fed (EFF) infants at the age of 3 months. Thus, PFASs could potentially reduce the health benefits of breastfeeding.

Objective: We investigated the associations between PFAS levels at the age of 3 months and accelerated gain in fat mass during the first 6 months of life, body composition at 2 years, and whether these associations differ between EBF and EFF infants.

Setting: In 372 healthy term-born infants, we longitudinally assessed anthropometrics, body composition (by air-displacement plethysmography and dual-energy X-ray absorptiometry), and visceral and subcutaneous fat (by abdominal ultrasound) until the age of 2 years.

Measures: The plasma levels of 5 individual PFASs were determined by liquid chromatography-electrospray ionization-tandem mass spectrometry at the age of 3 months.

Main outcomes: We studied associations between PFAS levels and outcomes using multiple regression analyses.

Results: Higher early life plasma perfluorooctanoic acid and total PFAS levels were associated with an accelerated gain in fat mass percentage [FM%; >0.67 SD score (SDS)] during the first 6 months of life. Higher early life PFAS levels were associated with lower fat-free mass (FFM) SDS at the age of 2 years, but not with total FM% SDS at 2 years. Furthermore, we found opposite effects of PFAS levels (negative) and exclusive breastfeeding (positive) at the age of 3 months on FFM SDS at 2 years.

Conclusion: Higher PFAS levels in early life are associated with accelerated gains in FM% during the first 6 months of life and with lower FFM SDS at the age of 2 years, which have been associated with an unfavorable body composition and metabolic profile later in life. Our findings warrant further research with longer follow-up times.

生命早期的多氟和全氟烷基物质 (PFAS) 含量与生命头两年的脂肪含量。
背景和目的:聚全氟烷基和全氟烷基化合物(PFAS)是一种不可降解的人造化学品。它们在人体内蓄积,具有潜在的有害影响,尤其是在人类发育的易感时期,如出生后的头几个月。我们发现,在我们的队列中,纯母乳喂养的婴儿(EBF)与纯配方奶喂养的婴儿(EFF)相比,3 个月大时血浆中的 PFAS 水平高出 3 倍。因此,PFAS 可能会降低母乳喂养对健康的益处。我们研究了 3 个月大婴儿体内的 PFAS 水平与出生后前 6 个月脂肪量加速增长、2 岁时身体组成之间的关系,以及这些关系在纯母乳喂养婴儿和纯配方奶粉喂养婴儿之间是否存在差异:我们对 372 名健康的足月出生婴儿进行了纵向评估,包括人体测量、身体成分(通过空气位移胸透(ADP)和双能 X 射线吸收测定法(DXA))以及内脏和皮下脂肪(通过腹部超声波),直至其 2 岁。通过液相色谱-电喷雾电离-串联质谱法(LC-ESI-MS/MS)测定了3个月大时血浆中5种PFAS的含量。我们使用多元回归分析法研究了 PFAS 水平与结果之间的关联:早期血浆中较高的 PFOA 和 PFAS 总含量与出生后 6 个月内 FM% 的加速增长(>0.67 SDS)有关。生命早期较高的 PFAS 水平与 2 岁时较低的游离脂肪量(FFM)SDS 有关,但与 2 岁时的总游离脂肪量 SDS 无关。此外,我们还发现 3 个月大时的 PFAS 水平(负作用)和纯母乳喂养(正作用)对 2 岁时的无脂肪体重 SDS 有相反的影响:结论:生命早期的 PFAS 水平较高会导致出生后头 6 个月的 FM% 增长加快,2 岁时的 FFM SDS 水平较低,这与日后不利的身体组成和代谢状况有关。我们的研究结果值得进行更长时间的后续研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Endocrinology
European Journal of Endocrinology 医学-内分泌学与代谢
CiteScore
9.80
自引率
3.40%
发文量
354
审稿时长
1 months
期刊介绍: European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica. The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology. Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials. Equal consideration is given to all manuscripts in English from any country.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信